Thursday, 14 June 2018

Ultrasonic Spirometers Market Latest Trends and Future Growth Study by 2026

Spirometer is an apparatus that measures the capacity of lungs. It is used to perform pulmonary function tests (PFT). The device specifically measures volume and speed (flow) of air inhaled and exhaled by lungs during breathing. Spirometers are helpful in assessing respiratory disorders such as asthma, emphysema, and bronchitis by inspecting ventilation i.e., obstructive and restrictive patterns of a lung. The airflow is measured by ultrasonic waves and Doppler effect technology. Recent advancements in sensor technology for ultrasonic spirometers enable the device to be optimized for home monitoring. Ultrasonic flow metering allows the manufacture of easy-to-use and low-maintenance spirometers.
Increase in preference for home-based diagnostic tools, efficient monitoring of pulmonary functions by ultrasound spirometers, and rise in prevalence of respiratory diseases such as asthma across the globe are likely to fuel the growth of the global ultrasonic spirometers market during the forecast period. However, lack of awareness about technological advancements in spirometers in developing countries and reimbursement issues for ultrasonic spirometers in some countries are projected to restrain the global ultrasonic spirometers market from 2018 to 2026.
The global ultrasound spirometers market can be segmented based on technology and end-user. In terms of technology, the global market can be classified into volume measurement, peak flow measurement, and flow measurement. The peak flow meters segment dominated the market in 2017 due to rise in prevalence of chronic obstructive pulmonary disorders (COPD) and aging global population. The segment is expected to continue to lead the market during the forecast period, owing to automatic internal calibration of ultrasonic spirometers and introduction of ultraviolet (UV) light assisted disinfection feature in the device by key manufacturers. However, rise in number of smokers across the globe and government participation in prevention & control of respiratory disorders are expected to propel the flow measurement segment from 2018 to 2026. In terms of end-user, the global ultrasonic spirometers market can be categorized into hospitals, clinics, home care settings, and others. The hospitals segment accounted for the largest market share in terms of revenue in 2017, attributed to rise in investment by public & private players for the betterment of healthcare sector in the developing countries, and favorable reimbursement policies. However, ultrasonic spirometers do not require daily external calibration, which is likely to propel usage in clinics and home care settings. Rise in number of patients with asthma and bronchitis owing to increasing air pollution is projected to boost the growth of the home care settings segment from 2018 to 2026.
Geographically, the global ultrasonic spirometers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2017, attributed to increase in strategic operations of key manufacturers in the U.S. and Canada and rise in per capita expenditure of the population on health care. Emergence of local & regional manufacturers for ultrasonic spirometers in Europe is expected to augment the market in the region during the forecast period. However, Asia Pacific is projected to be the fastest growing market for ultrasound spirometers from 2018 to 2026, due to rise in adoption of digital connectivity in diagnostic equipment, cost-efficient design of ultrasonic spirometers, and efficient integration in hospital information systems.
Key players operating in the global ultrasonic spirometers market include Vitality Medical, ndd Medizintechnik AG, KWIPPED, Inc., Henry Schein, Inc., Meditech Equipment Co., Ltd., Schiller AG, Welch Allyn, GE Healthcare, Uscom Ltd., Contec Medical Systems Co., Ltd., and Midmark Corp. Introduction of advanced features such as wireless connectivity in ultrasonic spirometers is a key focus of the manufacturers to stay ahead of the competition.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thin Film Drug Manufacturing Market is Rising at a Solid 9.0% CAGR Between 2016 and 2024

Competition is heating up in the global thin film drug manufacturing market owing to astute players betting big on new products by investing heavily in cutting edge research and development. Expanding of production facilities to satisfy the ever-surging global demand is another strategy being deployed by them.
To thrive in the challenging environment, players are also seen banking upon mergers and acquisitions to tap into the synergies. This is resulting in consolidation in the global market for thin film drug manufacturing. Indivior Plc., MonoSol Rx, IntelGenx Corp., and ZIM Laboratories Limited are to name a few companies that have reached a place of prominence by banking upon the aforementioned strategies.
A recent research study by Transparency Market Research finds that the global market for thin film drug manufacturing will likely become worth US$15.984 bn by 2024 by rising at a solid 9.0% CAGR between 2016 and 2024. It valued the market at US$7.338 bn in 2015.
Among the different types of thin film drug manufacturing, the oral thin film is expected to gross maximum revenue in the next few years. This is because of its myriad benefits such as ability to administer drugs via the oral mucosa, ease of handling and transportation, ability to eliminate the hepatic first pass effect, and early action. The segment is expected rise at a phenomenal two digit CAGR of 18.3% during the forecast period. From a geographical standpoint, North America, powered by the U.S. where superior pharmaceutical research and growing demand of novel drug delivery is maximum, leads the market. So much so, the U.S. held about 85.3% market share in 2016.
Developed European nations and the U.S. are at the forefront driving sales in the global market for thin film drugs on account of increased awareness about their solid efficiency in bringing about necessary therapeutic results and their ease of usage. Another reason why their demand in these nations is soaring is because of the absence of drawbacks of conventional forms of dosages in such novel products. Those include complicated administration and reduced bioavailability. On the contrary, they help administer appropriate dosages for the exact outcome. All such factors are catalyzing growth in the global market for thin film drug manufacturing. “Continued research and development, especially of innovative polymeric thin films, is also having a positive impact on the market,” adds the lead analyst of the report.
A trend observed in the market for thin film drug manufacturing is key players looking towards the under-tapped emerging markets, particularly in Asia Pacific. India, Japan, and China hold out a lot of promise and overall, the region is expected to be buoyed by unveiling of new products, rising awareness, and supportive regulations.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/11525
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Antimicrobial Ingredients Market is Poised to Expand at a CAGR of 4.1% Between 2017-2026

Improving the product safety is a top priority for participants in the global cosmetics industry. To ensure that their products are safe for human use, manufacturers of cosmetic products are using antimicrobial ingredients as additives in production techniques. Alcohols and other types of antimicrobial ingredients are being used in production of cosmetics, allowing the user to apply these products without being concerned about grave side-effects. Moreover, the role of antimicrobial ingredients in extending the product life is also supporting the robust end-use in the cosmetics landscape. Companies namely, Ashland Global Holdings Inc., BASF SE, Croda International Plc., Lonza Group Ltd., Clariant AG, The Dow Chemical Company, Solvay SA, Akzo Nobel N.V., Wacker Chemie AG, and Evonik Industries AG are expected to spearhead the global production of antimicrobial ingredients in the near future.
According to Transparency Market Research’s latest report, the global antimicrobial ingredients market is poised to register global sales of nearly 118,000 tons of antimicrobial ingredients by the end of forecast period, 2017-2026. During this period, the global market for antimicrobial ingredients is assessed to expand at a CAGR of 4.1% in terms of volume. The report has observed these companies as the key stakeholders in the global antimicrobial ingredients landscape.
Mexico and Brazil are among the leading producers of ingredients with antimicrobial properties. Relatively easy procurement of raw materials required to produce antimicrobial ingredients at a commercial scale continues to bolster Latin America’s antimicrobial ingredients market. In addition, low-wage skilled labor further aids the manufacturers, and increases the profit margins for players in the Latin American antimicrobial ingredients market. The report estimates that by the end of 2026, around 30% of antimicrobial ingredients produced in the world will translate into heavy revenues procured from Latin America. However, the report also projects that Europe and Asia-Pacific excluding Japan (APEJ) will represent fastest expansion by reflecting volume CAGRs above 5.5% during the forecast period.
The report has forecasted that by the end of 2026, antibacterial agents will emerge as the top-selling products in the global antimicrobial ingredients market. Increasing importance of protecting cosmetic products from common bacterial outgrowth will continue to fuel the demand for antibacterial agents in the global antimicrobial ingredients market. By the end of 2026, more than 32,000 tons of antibacterial agents are pegged to be sold globally. The report has also assessed a lucrative growth in demand for antifungal and anti-parasitic agents throughout the forecast period.
Majority of antimicrobial ingredients produced in the future will be used in manufacturing skin care products. By 2026-end, more than one-fourth of antimicrobial ingredients produced in the global market will be used in the production of skin care products. Hair care products is also expected to emerge as a key end-use of antimicrobial ingredients, and will register a volume CAGR of 4.2% over the forecast period. The report further estimates that antimicrobial ingredients will be predominantly manufactured in dry form over the foreseeable future. Limitations of liquid ingredients in terms of applications will continue to drive the scope for dry antimicrobial ingredients through 2026.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/39950
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Wearable Heart Monitoring Devices Market Share and Growth Factors Impact Analysis 2018 - 2026

A wearable heart rate monitor is a personal monitoring device. It enables real time measurement of heart rate. Wearable heart rate monitors are available in two forms: wrist bands and chest straps. These are especially designed to work in extreme conditions, and are compact and lightweight. Advanced models of heart rate monitors also provide activity, heart rate variation, breathing rate, and core temperature. The wrist band is a more popular heart rate monitoring device, as it provides comfort and is easy to use. However, it provides limited information as compared to chest strap. The accuracy of chest strap is higher as compared to the wrist watch. Wearable heart rate monitors are used by athletes and trainers to study and analyze their performance during sports activities. It is also used in hospitals for continuous monitoring of patients. Integration of technologies such as Bluetooth and Wi-Fi enable these devices to instantly transfer health information to computers or smartphones. This aids medical experts to analyze data quickly.
The global wearable heart monitoring devices market is expected to grow rapidly due to factors such as ease of use, low cost, rise in obesity among the population, and increase in awareness about fitness. Additionally, cardiac conditions such as atrial fibrillation (AFib) need continuous and extensive monitoring. According to the Centers for Disease Control and Prevention, 2.7 million to 6.1 million people in the U.S. suffered from AFib in 2017. Furthermore, it stated that over 750,000 people require hospitalization due to AFib in the country each year. The estimated medical cost for people suffering from AFib is about US$ 8,705 per person. Hence, rise in prevalence of atrial fibrillation along with increase in geriatric population and high per capita health care expenditure in the developed countries are projected to boost market growth during the forecast period. However, inconsistent and insufficient data is likely to hamper the growth of the global wearable heart monitoring devices market.
The global wearable heart monitoring devices market can be segmented based on product, type, application, end-user, and region. In terms of product, the global market can be classified into optical technology based, electric pulse based, and others. The optical technology based segment can be categorized into earphones, smart watches, and others. The electric pulse based segment can be divided into chest patches, chest straps, and others. Based on type, the global wearable heart monitoring devices market can be classified into Bluetooth enabled, chargeable, non-chargeable, and others. In terms of application, the global market can be categorized into health care, consumer market, and others. Based on end-user, the global wearable heart monitoring devices market can be divided into hospitals, retail pharmacies, academic institutes, and others.
Geographically, the global wearable heart monitoring devices market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region can be divided into specific countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC Countries. North America dominated the global wearable heart monitoring devices market because of high prevalence of AFib diseases and increase in health care expenditure. Moreover, presence of developed economies such as the U.S. and Canada and global players such as Medtronic and Briggs Healthcare fuel market growth. Asia Pacific is considered to be the most attractive market for wearable heart rate monitoring devices during the forecast period due to increase in health care expenditure and favorable government policies.
Key players operating in global wearable heart monitoring devices market are Kinetec Products UK Ltd., Medtronic, Beurer GmbH, Medisana AG, Briggs Healthcare, Polar Electro, SUUNTO, Koninklijke Philips N.V., and Garmin Ltd., among others.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Surgical Robotic Systems Market Competitive Landscape Analysis with Forecast by 2025

The growing trend of computer assisted or robotic minimally invasive surgery is expected to boost the growth of the market. Surgeons have adopted minimally invasive surgical (MIS) techniques for a wide range of applications such as cholecystectomy, appendectomy, prostatectomy, gastric bypass, ventral hernia repair, hysterectomy, colectomy, tubal ligation, and myomectomy. The number of cases of laparoscopic hysterectomy is projected to increase during the forecast period. About 96% of cholecystectomies is conducted laparoscopically. Hence, acceptance of and demand for surgical robots have risen in the last two decades. Surgical robots are medical devices that improve surgical outcomes by eliminating or reducing disadvantages in traditional surgery. Surgical robotic systems have been widely used for minimal invasive surgeries in specialties such as gynecology, cosmetology, open surgery, laparoscopic procedures, and flexible endoscopic procedures. These techniques cause minimal complications, reduce the risk of infections, cause less pain, and have faster recovery time which leads to shorter hospital stay in comparison with traditional therapies and treatments. These factors have helped in wide acceptance and adoption of surgical robotic systems by many medical facilities and centers.
The global surgical robotics systems market is driven by technological advancements in the health care industry, increase in geriatric population, and high prevalence of movement-restricting medical conditions. Surge in health care costs, lack of skilled health care personnel, and rise in cost of labor are also some of the factors that have led to demand for incorporation of lean operation methods in hospital management. However, high cost of surgical robots is a major factor restraining demand, especially in the developing markets.
The global surgical robotics systems market can be segmented based on product type, application, end-user, and region. In terms of product type, the global market can be classified into surgical systems, instrument & accessories, and services & maintenance. Based on application, the global surgical robotics systems market can be divided into orthopedic surgery, interventional cardiology, general surgery, neurological surgery, urological surgery, and others. Major surgical robots such as the da Vinci robotic system are the pioneers in the market. It was among the first robotic surgical systems to be introduced in the market. The device’s scope in performing a wide range of surgical procedures and established efficacy in performing such procedures are the major factors responsible for the rise in demand for these devices. By far, the da Vinci surgical system is viewed as the most versatile robotic surgical system available in the market, as it performs a wide range of surgical procedures. Constant innovation in the system and improvement in its operative efficiency have resulted into a feeling of trust among surgeons worldwide in installing this system in their facilities. Increase in the number of surgical procedures which could be performed via these systems is likely to propel the surgical robotic systems market.
Geographically, North America is the largest market for surgical robotic systems. Better reimbursement policies and existence of advanced health care infrastructure are the major drivers of the market in the region. The general population in North America is more aware about existence of health care robots and their added efficiency in surgical procedures and rehabilitation. The preference of medical practitioners for technologically advanced medical devices to enhance their productivity and eliminate redundant labor is high in North America. This is also propelling demand for medical robots in the region. On the other hand, improved health care infrastructure in the emerging economies in Asia Pacific, Latin America has given scope to establishment of new and more sophisticated healthcare facilities. This presents significant opportunity for the major players to introduce their robots in these regions.
Key players operating in the surgical robotic systems market are Intuitive Surgical, Inc., Accuray, Inc., Auris Surgical Robotics, TransEnterix, Inc., Think Surgical, Inc., Hansen Medical, Stryker Corporation, Smith & Nephew plc, Titan Medical Inc., and Zimmer Biomet Holdings, Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Albumin Market to Become Worth US$ 10.359 Billion by 2025

The presence of scores of prominent companies focused on product extension and service expansion increasingly account for the intense competition in the global albumin market, finds Transparency Market Research (TMR). The strategic landscape is further likely to heat up with well-placed players seeking to consolidate their position by entering into collaborations and partnerships with various pharmaceutical and biotechnology companies in various parts of the world. They are also inclined to acquire distribution rights to expand their sales across various geographic regions, in order to get a firm foothold in the global market, notes TMR.
Top players operating in the global albumin market include MedxBio Pte. Ltd., Thermo Fisher Scientific Inc., InVitria, HiMedia Laboratories Pvt. Ltd., Mitsubishi Tanabe Pharma Corporation, Sigma-Aldrich Co. LLC., Octapharma AG, Grifols International, and CSL Behring LLC, S.A.,
The opportunities in the global albumin market is projected to surge from US$4.8 bn in 2016 to US$10.359 bn by 2025 end. The market is estimated to garner a healthy CAGR of 9.2% during 2017–2025.
The key varieties of albumin used are human serum albumin (HSA), bovine serum albumin, and recombinant albumin. Of these, HSA, the most widely found protein in human plasma, contributed the major share in the global market in 2016. The segment is expected to retain its dominance and will clock 9.2% CAGR during 2017–2025. The growth is driven by extensive application of HSA as blood volumizer helpful in a variety of conditions such as chronic diseases, rare blood conditions, and transfusion therapies.
Regionally, Asia Pacific presently holds the sway accounting for the leading share. The regional market is projected to expand at a promising CAGR of 11.5% from 2017 to 2025. The growth is fueled by substantially rising demand for albumin in emerging economies, notably India and China. This can be attributed to its potential application for treating rare diseases and burns.
Serum albumin, the most abundant protein found in blood plasma occupies a vital role in regulating blood volume by regulating colloid osmotic pressure and acts as carrier proteins for various molecules, including hormones, bile salts, and ions. This is a key factor promoting its use for blood volumizer in various conditions and in a range of replacement therapies.
The wide popularity of recombinant albumin for being used as pharmaceutical excipient is a notable factor accentuating the market. The substantial use of human serum albumin as an excipient for various biotechnology products is contributing to the attractive revenue in the market. Moreover, the market is benefitting from the use of albumin reagent in various life sciences procedures.
The rising instance of shocks, burns, and traumatic injuries among worldwide population is boosting the demand for albumin. The wide application of albumin in a variety hypovolemic conditions is a noteworthy factor boosting the market. Bovine serum albumin is the type derived from cows is frequently used a component of cell culture media, thereby accentuating the market’s growth. Its vast potential in protein chemistry research and cell culture media is catalyzing the growth of the overall market.
The rising volume of elderly population in a number of developing and developed countries is a notable factor boosting the market. The rapidly rise in incidence of rare diseases, such as rare blood conditions, is expected to favor the expansion of the demand for albumin. The rise in production of vaccine in various parts of the world and a notably rising demand for biologics in several developing and developed nations are notable factors contributing to the rapid expansion of the market.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/3984
However, the growth of the albumin market is severely constrained by the lack of plasma fractionation in the pharmaceutical manufacturing industry and the emergence of viable alternatives for replacement therapies. Nevertheless, the market is expected to get a robust fillip from rising medical and clinical applications over the assessment period. Emerging, attractive prospects in this regard are medical imaging and nuclear medicine, expected to unlock promising prospects in the global market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Active Implantable Medical Devices Market is Expanding at a CAGR of 4.40% Between 2017 and 2025

A number of leading players in the global active implantable medical devices are investing extensively in the research and development of their new implants, finds a new research report by Transparency Market Research (TMR). These players are also involving into partnerships with hospitals and dermatologists to increase the sales of their products. Boston Scientific Corp., Abbott Laboratories, Medtronic Plc, Sonova Holding AG, LivaNova Plc, BIOTRONIK SE & Co. KG, Cochlear Ltd., William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., and MED-EL Medical Electronics are some of the leading players in the global market for active implantable medical devices. These players are expected to use innovative strategies to widen their product portfolio in order to improve their market position over the next few years, states the research report.
According to the research report, the opportunity in the global active implantable medical devices market is likely to expand at a CAGR of 4.40% over the period from 2017 to 2025 and reach a value of US$20.73 bn by the end of the forecast period. Implantable cardioverter defibrillators (ICDs) are registering a relatively greater demand and are anticipated to continue doing so over the forthcoming years.
Hospitals, ambulatory surgery centers (ASCs), and specialty clinics have surfaced as the key end users of active implantable medical devices across the world. Hospitals, among these, are expected to report a higher uptake of these device in the years to come. In terms of the region, North America led the global market in 2016 with a share of 33.5%. Researchers project the scenario to remain more or less the same over the forthcoming years, notes the market study.
“The increasing prevalence of cardiovascular and neurological disorders among people across the world is the main factor that has been influencing the growth of the global market for active implantable medical devices,” says the author of this research study. Apart from this, the market’s growth is also influenced by frequent product approvals and continual product launches. Companies are introducing innovative and novel products so as to maintain competitive advantage, carve new markets and lay foundation for sustained business growth, states the research report.
On the flip side, challenges related to the usage of active implantable medical devices, such as device failure and concerns related to cybersecurity, may hamper the growth of the worldwide market for active implantable medical devices in the years to come. However, the rising healthcare expenditure associated with the increasing number of patients with cardiovascular diseases (CVDs) and neurological disorders is likely to fuel the demand for active implantable medical devices, supporting the growth of this market over the next few years, reports the market study.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/37823
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)